1255 results about "Pyridyne" patented technology

The invention discloses a yellow reduction dyeing agent, a dyeing solution and a preparation method and application thereof, and relates to the technical field of dyeing and finishing. According to the yellow reduction dyeing agent provided by the invention, the 5-hydroxy-3-aminopyridine-2, 6-(1H, 3H)-diketone is adopted as a reduction dye, and the sodium sulfite is independently used as a reducing agent for reduction dyeing, so that the obtained dye leuco body is proper in dyeing capacity, and a dyed fabric can show excellent light brittle damage resistance. The fabric dyed by the dyeing agent has similar breaking strength before and after dyeing and even is slightly improved after dyeing and illumination, meanwhile, the color depth K / S of the fabric dyed by the dyeing agent reaches 3.2 or above, the dry and wet rubbing color fastness can reach level 4 or above, and the color fastness to illumination reaches level 6 or above.

The invention relates to a method for preparing a nerofloxacin chiral piperidylamine intermediate, which comprises the following steps of: carrying out condensation reaction on 5-hydroxy nicotinic acid which is simple and easy to obtain and is used as a raw material and different alcohols, screening through a series of asymmetric catalytic hydrogenation conditions to obtain optimal reaction conditions, and under the conditions, carrying out reaction on various 3, 3 '-dihydroxy nicotinic acid and 3, 3'-dihydroxy nicotinic acid to obtain the nerofloxacin chiral piperidylamine intermediate. The 2, 5-disubstituted pyridine quaternary ammonium salt is reduced into a tetrahydropyridine product, and the C5 site enantioselectivity of the product is excellent. The preparation method comprises the following steps: selecting methyl (R)-1-benzyl-5-hydroxy-1, 4, 5, 6-tetrahydropyridine-3-carboxylic acid methyl ester as a substrate, completely hydrogenating by using platinum dioxide hydrogen, and then carrying out methyl ester reduction, dehydroxylation, Mitsunobu reaction and protecting group removal to obtain a key chiral intermediate for industrial synthesis of a quinolone antibacterial drug nemonofloxacin with high enantioselectivity and high yield.

Provided herein are inhibitors of KRAS, pharmaceutical compositions comprising the inhibitory compounds, and methods for using the KRAS inhibitory compounds for the treatment of diseases or disorders.

The invention relates to the technical field of organic synthesis, and particularly discloses a synthesis process of 2-chloronicotinic acid. The synthesis process of the 2-chloronicotinic acid comprises the following steps: S1, mixing water, concentrated sulfuric acid, 3-cyanopyridine and a composite catalyst, performing pre-reaction, adding hydrogen peroxide, performing oxidation reaction, adjusting pH, performing solid-liquid separation, and washing to obtain an oxide intermediate; s2, in an inert atmosphere, adding phosphorus oxychloride into a reactor, adding the oxide intermediate and triethylamine for a chlorination reaction, recovering phosphorus oxychloride after the reaction is finished, hydrolyzing remaining materials, and performing solid-liquid separation and washing to obtain chloride; and S3, carrying out alkali dissolution, neutralization, decoloration and acidification on the chloride, carrying out solid-liquid separation, washing, carrying out secondary alkali dissolution, neutralization and secondary decoloration, adding a complexing agent, carrying out secondary acidification, carrying out solid-liquid separation, washing, drying and crushing to obtain the 2-chloronicotinic acid. The 2-chloronicotinic acid prepared by the method disclosed by the invention has relatively high purity and yield.

The invention relates to the technical field of metal powder material preparation, and particularly discloses antimony-doped cesium terbium chloride microcrystalline powder and a preparation method thereof. The chemical composition of the microcrystalline powder is Cs < 5 > Tb < 1-x > Sb < x > Cl < 8 >. 6H < 2 > O, wherein x is equal to 0.05 to 0.30. The preparation method comprises the following steps: mixing cesium chloride, terbium chloride hexahydrate and antimony trichloride according to a molar ratio of 5: 0.8: x; adding pyridine hydrochloride as a chlorine element supplement, wherein the dosage of the pyridine hydrochloride is that 0.05-0.20 mmol of Py.HCl is used for every 1 mmol of CsCl; adding stearic acid as a process dispersant; and through combined treatment of mechanical ball milling and freeze drying, antimony-doped cesium-terbium-chlorine microcrystal powder with regular morphology and good dispersibility is obtained. The method is simple in process and mild in condition, particle aggregation can be effectively inhibited, the crystallinity and dispersion uniformity of the powder are improved, and the prepared microcrystal powder shows excellent optical performance.

The invention relates to the technical field of nuclear waste treatment, in particular to a cucurbituril-based supramolecular organic framework material as well as a preparation method and application thereof. A construction unit of the supramolecular organic framework material is constructed by taking cucurbit [8] uril (CB8) as a subject and terephthalyl viologen ligand 1, 1 ''-(1, 4-phenylene) bis ([4, 4 '-bipyridyl]-1-onium) salt (PBV. 2X) as an object through the bonding effect of the subject and the object; in the molecular structure of the supramolecular organic framework material, the construction units are staggered and stacked in parallel in the space, and NO3 <-> is located at the gap of the adjacent CB8. The supramolecular organic framework material disclosed by the invention has high structural stability and cationic framework characteristics, and a rigid framework and a pyridine conjugated system of CB8 endow the material with excellent chemical / irradiation stability, so that the material shows ultrahigh removal rate on ReO4 <-> / TcO4 <-> in extreme environments (strong acid, strong alkali and high irradiation).

The invention relates to the technical field of synthesis of chlorine-containing pyridine intermediates, and discloses a preparation method of 3, 4, 5-trichloropyridine, which comprises the following steps: step 1, feeding: adding raw materials 2, 3, 4, 5-tetrachloropyridine, an acid-binding agent, a solvent and a catalyst into a reaction kettle; 2, reaction preparation: sealing the reaction kettle, and replacing with hydrogen to remove air; step 3, dechlorination reaction: heating to 60-150 DEG C, maintaining the pressure at 0.6-2.0 MPa, and reacting for 8-30 hours; 4, post-treatment: after the reaction is completed, cooling to room temperature, and filtering reaction liquid to recover the catalyst; and 5, purification: distilling the filtrate to remove the solvent, adding water, stirring, filtering to obtain a crude product, and recrystallizing to obtain the 3, 4, 5-trichloropyridine product. According to the invention, the dechlorination reaction is carried out in a metal catalysis manner, the reaction steps are few, the used reagent raw materials are fewer and milder, the danger in the reaction process is reduced, and the method is safer; the reaction does not generate waste salt and is more environment-friendly; the catalyst can be recycled, so that the cost is reduced.

The invention belongs to the field of medicine, health and health, and particularly relates to a preparation method for controllably synthesizing polysulfonic acid mucopolysaccharide with different molecular weights, which comprises the following steps: reaction, acid-base neutralization, formamide removal by alcohol precipitation, desalting and freeze-drying. Wherein the reaction process comprises the following steps: adding sodium chondroitin sulfate and a pyridine sulfur trioxide complex into a mixed solvent of N, N-dimethylformamide and dimethyl sulfoxide, and heating for reaction to obtain a reaction mixture; the volume fraction of the dimethyl sulfoxide in the mixed solvent is 0-80%. According to the method, the low-price pyridine sulfur trioxide complex (about 150 yuan / 500g) is used, and the ratio of N, N-dimethylformamide to dimethyl sulfoxide in the mixed solvent is adjusted, so that the solubility of the chondroitin sulfate sodium and the pyridine sulfur trioxide complex is changed, and the polysulfonic acid mucopolysaccharide with molecular weights in different ranges can be regulated and generated.

The invention discloses a preparation method and application of a catalyst based on pyridine ionic liquid, and belongs to the technical field of catalyst preparation. According to the invention, a hydrolysis reaction of a silane coupling agent is utilized to prepare a silicon oxide nanotube containing a pyridine unit, and then a quaternization reaction is carried out to obtain the catalyst based on the pyridine ionic liquid. The catalyst has a high specific surface area and a rich pore channel structure, exposure of active sites and contact of the active sites and reactants are facilitated, and the catalytic rate is increased. Meanwhile, the silicon oxide nanotube contains hydroxyl, and can cooperate with a pyridine ionic liquid site to catalyze a carbon dioxide cycloaddition reaction. The obtained catalyst can catalyze the reaction of carbon dioxide and an epoxy compound to prepare cyclic carbonate under solvent-free and metal-free conditions, and the catalyst is easy to recover and simple in product purification, and has a good application prospect.

The invention discloses application of a carbon steel corrosion inhibitor based on combination of physical adsorption, chemical adsorption and hydrophobic barrier, and relates to the technical field of metal corrosion inhibition. The technical problem that a corrosion inhibitor in the prior art is low in corrosion inhibition efficiency in a high-temperature strong-acid environment is solved. The preparation method of the carbon steel corrosion inhibitor comprises the following steps: firstly, ultrasonically dissolving 4-aminopyridine to obtain a solution I; then, dropwise adding an isopropanol solution of 2, 3-epoxypropyltrimethylammonium chloride into the solution I according to a molar ratio of 1: 1, removing a solvent through a rotary evaporation method, washing with ethanol, centrifuging to obtain quaternized 4-aminopyridine, and drying the quaternized 4-aminopyridine; and finally, the dried quaternized 4-aminopyridine and bromododecane are added into acetonitrile for a reaction, diethyl ether is dropwise added into obtained reaction liquid for precipitation, and the quaternized 4-aminopyridine-bromododecane carbon steel corrosion inhibitor is obtained after drying. The prepared carbon steel corrosion inhibitor is high in corrosion inhibition efficiency in a high-temperature and strong-acid environment.

The invention discloses a preparation method of 2-chloro-4-(4-fluoro-2-methylphenyl)-5-aminopyridine as an elinnetin intermediate, and belongs to the technical field of medicine synthesis. According to the invention, cheap and easily available 3-nitro-4-hydroxypyridine is used as an initial raw material, and the 2-chloro-4-(4-fluoro-2-methylphenyl)-5-aminopyridine is synthesized at low cost and high yield through the steps of halogenation, coupling, hydroxylation, reduction, condensation and the like. The raw materials used in the whole process are simple and easy to obtain, the reaction conditions are milder, and the reaction route is short. According to the invention, the Suzuki coupling reaction is firstly carried out, and then the hydroxylation of the pyridine 2 position is carried out, so that the use of an anhydrous reagent and harsh anhydrous reaction conditions are effectively avoided, and the reaction cost is remarkably reduced. In addition, the method is easy and convenient to operate, good in stability, high in total yield and suitable for industrial large-scale production.

The invention provides a preparation method of picoxystrobin, and belongs to the technical field of bactericides. According to the preparation method of picoxystrobin, no intermediate needs to be separated in the preparation process, side reactions are few, production operation is simpler, the product yield and purity are high, and the preparation method is suitable for industrial production. And the etherification reaction raw material used in the invention is 2-chloro-6-trifluoromethylpyridine, has no large corrosivity or safety risk, is convenient for post-treatment, has low requirements on production equipment, and is lower in cost.

The invention discloses a crystal compound, a preparation method thereof and application of the crystal compound in X-ray detection, imaging and anti-counterfeiting encryption, and belongs to the technical field of crystals. The molecular formula of the crystal compound is [Cu (totp) (CH3CN) 3] [Cu2I3 (totp) (PN)]. (CH3CN), wherein totp is tris (o-tolyl) phosphine; and PN is diphenyl-2-pyridine phosphine. The crystal compound disclosed by the invention is simple in preparation method, and has the characteristics of large mass attenuation coefficient of X-ray energy, high light yield and low detection limit when being used as a material of an X-ray detector. The compound also has the characteristic of structural transformation in solvents such as methanol, ethanol, acetone, dichloromethane, tetrahydrofuran and the like, and meanwhile, the conversion of luminescence color under the excitation of 365nm ultraviolet light and X rays is accompanied. The material can be applied to the aspects of scintillator materials, room-temperature X-ray radiation indirect detection materials, radiation detection dosimeters, X-ray scintillator medical imaging, anti-counterfeiting encryption and the like.

The invention relates to the technical field of organic synthesis, in particular to 4-chloro-1-methyl-6H-heterochromene [3, 4-c] pyridine as well as a synthesis method and application of the 4-chloro-1-methyl-6H-heterochromene [3, 4-c] pyridine. The synthesis method comprises the following steps: (1) synthesizing 2-chloro-3-fluoro-4-iodine-5-methylpyridine from 2-chloro-3-fluoro-5-methylpyridine and an iodine elementary substance to obtain 2-chloro-3-fluoro-4-iodine-5-methylpyridine; (2) synthesizing 2-(2-chloro-3-fluoro-5-methylpyridine-4-yl) benzaldehyde from the 2-chloro-3-fluoro-4-iodo-5-methylpyridine, the 1, 1-bis (diphenylphosphine) ferrocene palladium dichloride, the tripotassium phosphate and the (2-formyl phenyl) boric acid, and further synthesizing the 2-(2-chloro-3-fluoro-5-methylpyridine-4-yl) benzaldehyde from the 2-chloro-3-fluoro-4-iodo-5-methylpyridine and the 1, 1-bis (diphenylphosphine) ferrocene palladium dichloride. And (3) synthesizing the 4-chloro-1-methyl-6H-heterochromene [3, 4-c] pyridine by using the 2-(2-chloro-3-fluoro-5-methylpyridine-4-yl) benzaldehyde and sodium tert-butoxide. The 4-chloro-1-methyl-6H-heterochromene [3, 4-c] pyridine compound constructed by the invention can be used for detecting the content of pesticide residue glyphosate.

The present invention relates to pharmaceutical compositions containing N-(1,3-dimethylpyrazol-4-yl)sulfonyl-6-[3-(3,3, 3-trifluoro-2,2-dimethyl-propoxy)pyrazol-1-yl]-2-[(4S)-2,2,4-trimethylpyrrolidin-1-yl]pyridine-3-carboxamide, a solid dispersion of (R)-1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)-7V-(1-(2,3-dihydroxypropyl)-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1H-en indol-5-yl)cyclopropanecarboxamide, and a solid dispersion of N-[2,4-Bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxo-quinoline-3-carboxamide, including formulations of the solid dispersions into powders, granules and mini-tablets, methods for manufacturing and processing the powders, granules and mini-tablets, and methods for treating cystic fibrosis employing the pharmaceutical compositions.

The invention belongs to the technical field of biological detection, and particularly relates to a bisulfite-free detection kit for specific site 5-methylcytosine and a detection method thereof. According to the method, a TAPbeta treatment method is adopted, 5hmC is sealed through beta-GT, 5mC oxidation is carried out through TET, and 5mC is reduced into dihydrouracil (DHU) through pyridine borane, so that the apparent difference between 5mC and C and 5hmC is converted into single nucleotide polymorphism difference. In addition, a flow microsphere technology based on PNA-assisted click chemical connection starting is established to detect DNA methylation specific sites. A PNA clip is innovatively introduced into click chemical connection, and non-specific connection is inhibited. Target sequence enrichment, signal amplification and signal acquisition are carried out through surface-functionalized magnetic nanoparticles, and the detection sensitivity is improved to fM. The invention provides a new tool for high-specificity and high-sensitivity epigenetic marker detection.

The invention discloses preparation of a nitrogen-rich ionic organic single crystal material and application of the nitrogen-rich ionic organic single crystal material in iodine adsorption, and belongs to the technical field of functional materials and radioactive pollutant treatment. The material is formed by self-assembly at room temperature through a solution method by taking biphenyl tetracarboxylic acid tetrabutylamine as an anion ligand and tetra (4-ethyl pyridine phenyl) ethylene bromide or tetra (4-imidazole phenyl) ethylene bromide as a cation ligand. The method is simple in preparation process, mild in condition and high in yield. The skeleton of the obtained material is rich in nitrogen sites and has a large cavity, the material shows extremely high adsorption capacity and rapid adsorption kinetics for iodine in a gas phase and a liquid phase, the maximum adsorption capacity of the material for iodine steam reaches up to 5.16 g / g, the retention rate of 95% or above can still be kept within 7 days after adsorption, and the material has good recycling performance. The material provides a novel and reliable solution for efficiently capturing and fixing radioactive iodine, and has a wide application prospect in the field of nuclear waste treatment.

The invention discloses a water treatment filtering material and a preparation method thereof, and relates to the technical field of water treatment. When the water treatment filtering material is prepared, alkaline lignin, epichlorohydrin and triethylenetetramine are subjected to a reaction through a reverse suspension cross-linking technology, and lignin porous microspheres are prepared; carrying out reaction on the lignin porous microspheres and picolinamide ligands to obtain modified lignin porous microspheres; 3-mercaptopropyltriethoxysilane and titanium dioxide are subjected to a reaction, and modified titanium dioxide is prepared; the preparation method comprises the following steps: reacting pyromellitic dianhydride, 1, 4-diaminobutylene and 4 ', 4-diaminodiphenyl ether to prepare functionalized polyamide; the functional polyamide, the modified lignin porous microspheres and the modified titanium dioxide are prepared into a spinning solution, and a polyamide membrane is prepared through electrostatic spinning; and carrying out liquid reaction on bromohexane on the polyamide membrane to obtain the water treatment filtering material. The prepared water treatment filtering material has excellent antibacterial property, heavy metal adsorption property, dye removal property and mechanical property.

The invention discloses a folic acid modified active oxygen response type sodium alginate nano-carrier and application thereof, and the preparation method comprises the following steps: firstly synthesizing-Se-Se-FA: stirring dicyclohexylcarbodiimide, 4-dimethylaminopyridine, dimethyl sulfoxide / pyridine, a double-selenium fragment and folic acid at room temperature for 18-22 hours in an argon environment; and carrying out acetone precipitation, centrifugation, washing, rotary evaporation concentration and freeze-drying. The preparation method comprises the following steps: preparing an ALG-Se-FA carrier, stirring sodium alginate, 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide hydrochloride and hydroxysuccinimide in a 2-morpholinoethanesulfonic acid buffer solution, adding DMSO, dissolving a double-selenium fragment and a-Se-Se-FA fragment in DMSO and deionized water, adding the dissolved double-selenium fragment and-Se-Se-FA fragment into a system, stirring, dialyzing, and freeze-drying to obtain the product. According to the carrier, a double-selenium bond ROS response unit and folic acid targeting molecules are introduced through covalent bonds, astaxanthin can be efficiently entrapped and protected, and after the carrier is stable in gastrointestinal environment and reaches a colitis disease part, high ROS level can be responded, and intelligent drug slow release is achieved through folic acid receptor targeting.

The invention discloses a fluorescent probe for targeting mitochondrial ferric ions as well as preparation and application of the fluorescent probe. The fluorescent probe is prepared by reacting cucurbit [7] uril with (E)-4-(4-(dimethylamino) styryl)-1-(3-(triphenylphosphonium) propyl) pyridine-1-onium bromide according to a molar ratio of 1: 1. The fluorescent probe can be used for detecting Fe < 3 + > ions, and has the characteristics of simple preparation method, convenience in operation, high sensitivity, high selectivity, low cost and rapidness in detection.

The invention discloses a synthesis method of a mono / dibromo pyridine derivative, which comprises the following steps: reacting a pyridine derivative with dimethyl butynedioate and methyl pyruvate at room temperature by using acetonitrile as a solvent to generate a dearomatized heteroaromatic compound; in an oxygen environment, copper bromide is used for brominating the dearomatized heteroaromatic compound to realize dibromination, and if potassium carbonate is additionally added in the reaction, monobromination is realized; and finally, respectively generating mono / dibromopyridine derivatives under hydrochloric acid hydrolysis. A carbon halogen bond of bromopyridine has very high activity, and various reactions such as Suzuki coupling, Sonogashira coupling, Heck reaction, amination reaction and the like can be carried out. On the basis, the polysubstituted bromopyridine can be subjected to selective reaction, and many new ideas can be provided for organic synthesis. The method disclosed by the invention is simple and safe to operate and environment-friendly, the cost is lower by using the copper bromide, and the required reaction conditions are simple.

The use of a combination of a pyrido[2,3-d]pyrimidin-2(1H)-one derivative and an anti-PD-1 or anti-PD-L1 antibody and / or a chemotherapeutic drug in the preparation of a drug for preventing or treating a tumor disease.

The invention relates to the technical field of catalytic synthesis, in particular to a chloromethylation catalyst, a preparation method of the chloromethylation catalyst and a method for preparing high-purity ortho-position, meta-position and para-position chloromethyl styrene through the chloromethylation catalyst, and the chloromethylation catalyst is prepared by loading sulfonic acid compounds and (or) pyridine compounds and (or) copper salt on a molecular sieve. The method can improve the localization selectivity of chloromethylation. The method for preparing high-purity ortho-position, meta-position and para-position chloromethyl styrene comprises the following steps of: reacting beta-bromophenylethane, paraformaldehyde and lewis acid in the presence of the chloromethylation catalyst to generate chloromethyl beta-bromophenylethane, and then performing elimination reaction under an alkaline condition to generate a chloromethyl styrene crude product; the high-purity ortho-position, meta-position and para-position chloromethyl styrene is obtained after the crude product is rectified, the brand-new catalyst is adopted in the method, the reaction selectivity is enhanced, the process is simple, and industrial production is facilitated.

The invention provides an acid-resistant and anti-pollution composite nanofiltration membrane as well as a preparation method and application thereof, and relates to the technical field of membrane materials. The preparation method comprises the following steps: soaking the surface of a support membrane with a mixed solution I; the mixed solution I is prepared from doxycycline, 4-aminopyridine and deionized water; pouring an oil phase solution into the surface of the soaked support membrane to carry out interfacial polymerization reaction; the oil phase solution is composed of 1, 3-benzene disulfonyl chloride and cyclohexane; and carrying out heat treatment on the support membrane after the interfacial polymerization reaction to obtain the acid-resistant anti-pollution composite nanofiltration membrane. According to the prepared composite nanofiltration membrane, doxycycline is selected as a water-phase monomer for the first time, meanwhile, 1, 3-benzene disulfonyl chloride is selected as an oil-phase monomer, 4-aminopyridine is selected as an additive, and the prepared composite nanofiltration membrane not only has acid resistance and pollution resistance, but also has high permeation flux and high separation performance.

The invention provides a preparation method of a pyrazolopyridine derivative (formula (I)). The method has the advantages of mild reaction conditions, simple operation, high reaction yield, high product purity and convenient post-treatment, and is suitable for industrial production.

The application discloses an alkali ion type covalent organic framework material and a preparation method and application thereof, wherein 2,4,6-tris(4-formylphenyl)-1,3,5-triazine, 1,4-diisocyanobenzene and 2-aminopyridine are used as building units, a covalent organic framework containing pyrimidine is obtained through a condensation reaction, and then a quaternary ammonium reaction and an ion exchange reaction are sequentially performed to obtain the alkali ion type covalent organic framework.The alkali ion type covalent organic framework material prepared by the application has rich alkali sites, developed pore structures and good chemical stability, exhibits good catalytic performance as a catalyst for one-pot preparation of dimethyl carbonate from CO2, an epoxide compound and methanol, and also shows good cycle stability.

The invention discloses a 2-amino-4-(5-cyano-1-isopropyl-1H-indole-3-yl) pyrimidine compound and application thereof, the compound has the following structural general formula: in the formula, substituent R is substituted phenyl, the number of substituent groups on the benzene ring of the substituted phenyl is 1-2, and the substituent groups on the benzene ring of the substituted phenyl are 1-2. Substituent groups are respectively and independently selected from nitro, cyano, halogen, carbamoyl, furyl or pyridyl. The 2-amino-4-(5-cyano-1-isopropyl-1H-indole-3-yl) pyrimidine compound designed and synthesized by the invention is a novel efficient NF-kappa B induced kinase (NIK) inhibitor, and is suitable for drug development taking NF-kappa B induced kinase (NIK) as a target spot, and the obtained drug can be used for treating malignant tumors such as leukemia, multiple myeloma and the like.

The invention relates to a preparation method of a drug intermediate 2-amino-3-hydroxypyridine, and relates to the technical field of medicines. Adding water, acid, sodium chloride, furfural and a sulfamate solution into the reaction kettle, and stirring for reaction; after the reaction is finished, carrying out centrifugal separation to obtain 2-imino-3-hydroxypyridine sulfonic acid; the preparation method comprises the following steps: adding water and 2-imino-3-hydroxypyridine sulfonic acid into a reaction kettle, heating and stirring to react, adding modified amino phosphonic acid type chelating resin, stirring and adsorbing, adjusting the pH value to 6-8 by using an inorganic alkali solution, centrifuging and drying to obtain 2-amino-3-hydroxypyridine; the modified amino phosphonic acid type chelating resin is prepared from amino phosphonic acid type chelating resin, 10 # white oil, aluminum chloride and 5-quinoline sulfonyl chloride. According to the method, the 2-amino-3-hydroxypyridine with higher yield and purity can be obtained, and the method has a good industrial application prospect.

The application belongs to the field of organic synthesis, and particularly relates to a synthesis method of 2-(3,3-dimethylbutyl)pyridine. 2-vinylpyridine, brominated tertiary butane, a mixed solution of dimethyl ether and isopropyl ether as a reaction system solvent, nickel iodide as a nickel salt, bipyridine as a ligand, dicyclohexylmethylamine as a base in the system, 2,6-dimethyl-3,5-diethyl-1,4-dihydropyridine as a reducing agent, a photocatalyst 2,4,5,6-tetrakis(9 ‑ Carbazole) - m-phenylenedinitrile, under the condition of room temperature and nitrogen atmosphere, a reduction cross-coupling reaction is used to synthesize 2-(3,3-dimethylbutyl)pyridine. The application uses inexpensive nickel metal as a catalyst, constructs a cross-coupling reaction of carbon-carbon bond, and has the advantages of mild reaction condition, high economy and the like.

Provided herein are crystalline salt and free base forms and amorphous forms of a compound having the following formula (I): (I) Compound 1. Also provided are pharmaceutical compositions comprising such crystalline and amorphous forms, processes for their manufacture and their use for the treatment of various conditions such as hemolytic anemia, sickle cell disease and MDS (very low risk MDS, low risk MDS, lower risk MDS and / or moderate risk MDS).